Article: T-cell/histiocyte-rich large B-cell lymphoma: review on pathologic diagnosis, current therapeutic options and new targets for therapy

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma